Zero tolerance for counterfeit medicines
Date
27 May 2008
Sections
Health & Consumers
Counterfeit medicines, already widespread in the developing world, are now being found increasingly in the EU. While Internet-based sales are the main source of counterfeit medicines, these products are also appearing in the traditional supply chain. Urgent measures are required to protect European patients,
including a ban on medicine repackaging.
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
09 Apr 2024
Jobs
StP Communications
Max Planck Institute for Legal History and Legal Theory
European Partnership for Democracy
Friends of the Earth Europe
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
EuRIC aisbl
Bellona Europa
EBF - European Banking Federation
Cambridge Econometrics